Retrospective multicenter study for comparison of two surgical techniques (LAP vs. LSK) as therapy of early-staged ovarian cancer and borderline-tumor of the ovaries in regards to intra- and postoperative complications, oncological outcome and fertility preservation.
- Conditions
- C56Malignant neoplasm of ovary
- Registration Number
- DRKS00013084
- Lead Sponsor
- niversitätsklinikum des Saarlandes
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 120
Included are all patients who got surgical treatment for early-staged malignant neoplasms of the ovaries and borderline-tumors of the ovaries at University Medical Center Homburg/Saar from 01/1998 to 07/2017.
Furthermore, in a second step, all patients with similar criteria, who got surgical treatment in one of our cooperating medical centers are included.
Early-staged tumors are T1 and T2 stage tumors.
Subsequently the patients will be separated in two groups: laparoscopic treatments versus open surgical treatment via abdominal incision.
1. Laparoscopy because of benign neoplasms of the ovaries.
2. Minimally-invasiv surgery at advanced ovarial carcinoma.
3. Incomplete data.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoints are the relapse-free survival and the overall survival of the patients.<br>Therefore a Follow-Up off all included patients will be made. On the one hand this will be achived through retrospective data research and on the other hand through communication with the patients. Women who underwent surgical treatment recently (2017) will be followed-up prospectively over a period of approximately 10 years in addition.
- Secondary Outcome Measures
Name Time Method Secondary endpoints are the surgical outcome like surgery time, blood loss, intra- and postoperative complications and postoperative hospital stay. In women who got fertility-conserving surgery the fertility will also be a secondary endpoint.<br>These parameters will be collected via data research out of digitized and archived medical records.